NCT00003171View on ClinicalTrials.gov

Bryostatin 1 in Treating Patients With Myelodysplastic Syndrome

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

May 31, 1998

Primary Completion Date

July 31, 1999

Study Completion Date

June 30, 2003

Conditions
LeukemiaMyelodysplastic Syndromes
Interventions
DRUG

bryostatin 1

Trial Locations (1)

48201

Barbara Ann Karmanos Cancer Institute, Detroit

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Barbara Ann Karmanos Cancer Institute

OTHER